Acetildenafil

CAS No. 831217-01-7

Acetildenafil( —— )

Catalog No. M21166 CAS No. 831217-01-7

Acetildenafil is an analog of the phosphodiesterase inhibitor sildenafil.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 48 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Acetildenafil
  • Note
    Research use only, not for human use.
  • Brief Description
    Acetildenafil is an analog of the phosphodiesterase inhibitor sildenafil.
  • Description
    Acetildenafil is an analog of the phosphodiesterase inhibitor sildenafil.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    Neurological Disease
  • Indication
    Dysmenorrhea

Chemical Information

  • CAS Number
    831217-01-7
  • Formula Weight
    466.58
  • Molecular Formula
    C25H34N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:3.3mg/ml(7.07mM)
  • SMILES
    CCCc1nn(C)c2c(=O)[nH]c(-c3cc(C(=O)CN4CCN(CC)CC4)ccc3OCC)nc12
  • Chemical Name
    5-[2-Ethoxy-5-[2-(4-ethylpiperazin-1-yl)acetyl]phenyl]-1-methyl-3-propyl-4H-pyrazolo[43-d]pyrimidin-7-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Venhuis B J Blok-Tip L Kaste D D . Designer drugs in herbal aphrodisiacs[J]. Forensic Science International 2008 177(2-3):0-0.
molnova catalog
related products
  • p-(2-Methoxyethyl) p...

    An important kind of pharmaceutical intermediates, mainly used in the manufacture of effective drugs in the treatment of cardiovascular disease metoprolol.

  • MC-Val-Ala-PAB-PNP

    MC-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

  • 5-O-Coumaroylquinic ...

    5-O-Coumaroylquinic acid has a considerable inhibitory effect on PTP1B.5-O-Coumaroylquinic acid( 3-O-Coumaroylquinic acid) shows a significant concentration-dependent inhibitory effect on α-glucosidase, so it has anti-hyperglycemic effect.5-O-Coumaroylquinic acid(3-O-Coumaroylquinine acid) enhances glucose uptake and inhibits PTP1B in vitro.